Log In
BCIQ
Print this Print this
 

TRPH 011

  Manage Alerts
Collapse Summary General Information
Company PharmAbcine Inc.
DescriptionHuman bispecific antibody targeting vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1; VEGFR-2) and tyrosine kinase receptor 2 (Tie2)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1) ; Tyrosine kinase receptor 2 (Tie2)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today